EMPLOYMENT CONTRACTEmployment Contract • December 12th, 2014 • Prosensa Holding N.V. • Pharmaceutical preparations
Contract Type FiledDecember 12th, 2014 Company IndustryProsensa Holding B.V., a limited liability company under Dutch law, having its registered office at J.H. Oortweg 21, 2333 CH Leiden, The Netherlands, represented by its Supervisory Board which is represented by the chairman Daan Ellens, hereinafter referred to below as ‘Prosensa’;
FORM OF DIRECTOR INDEMNIFICATION AGREEMENTForm of Director Indemnification Agreement • December 12th, 2014 • Prosensa Holding N.V. • Pharmaceutical preparations
Contract Type FiledDecember 12th, 2014 Company IndustryTHIS DIRECTOR INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [date] between Prosensa Holding N.V., a public company with limited liability incorporated under the laws of the Netherlands (the “Company”), and [name of managing or supervisory director] (“Indemnitee”).
MUTUAL NON-DISCLOSURE AGREEMENTMutual Non-Disclosure Agreement • December 12th, 2014 • Prosensa Holding N.V. • Pharmaceutical preparations • California
Contract Type FiledDecember 12th, 2014 Company Industry JurisdictionThis Mutual Non-Disclosure Agreement (the “Agreement”), effective July 31, 2014 (the “Effective Date”), is by and between BioMarin Pharmaceutical Inc., a Delaware corporation, with offices at 105 Digital Drive, Novato, CA 94949 (“BioMarin”), and Prosensa Holding N.V., a Netherlands corporation with offices at J.H. Oortweg 21, 2333 CH, Leiden, The Netherlands. (“Prosensa”). Each of BioMarin and Prosensa may be referred to herein as a “Party” or collectively as the “Parties.”
FORM OF TENDER AND SUPPORT AGREEMENTTender and Support Agreement • December 12th, 2014 • Prosensa Holding N.V. • Pharmaceutical preparations • New York
Contract Type FiledDecember 12th, 2014 Company Industry JurisdictionThis TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of November 21, 2014, is entered into by and among [ ][, a [ ]] (“Shareholder”), among BioMarin Pharmaceutical Inc., a Delaware corporation (“Parent”), and BioMarin Falcons B.V., a private company with limited liability organized under the laws of The Netherlands and a wholly owned indirect subsidiary of Parent (“Buyer”).
FORM OF CONTINGENT VALUE RIGHTS AGREEMENT BETWEEN BIOMARIN PHARMACEUTICAL INC., BIOMARIN FALCONS B.V. and [RIGHTS AGENT] Dated as of [ ]Value Rights Agreement • December 12th, 2014 • Prosensa Holding N.V. • Pharmaceutical preparations • New York
Contract Type FiledDecember 12th, 2014 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [—] (this “Agreement”), is entered into by and between BioMarin Pharmaceutical Inc., a Delaware corporation (“Parent”), BioMarin Falcons B.V., a private company with limited liability organized under the laws of The Netherlands and a wholly owned indirect subsidiary of Parent (“Buyer”), and [—], a [—], as Rights Agent.